Luminopia Collaborates with Crunchyroll to Continue Building Its Extensive Content Library for Pediatric Lazy Eye Patients

Crunchyroll

Luminopia, a digital health company pioneering a new class of treatments for neuro-visual disorders, has announced a collaboration with Crunchyroll.

This collaboration will bring beloved anime content to Luminopia’s platform, diversifying and expanding its content options for children with amblyopia, or lazy eye, using Luminopia. By partnering with Crunchyroll, Luminopia is offering even more TV episodes that resonate with young audiences and providing kids with the option to watch a wider variety of content as treatment. 

Lazy eye affects about one million pediatric patients nationwide and is the leading cause of vision loss in children. Luminopia offers a modern, FDA-cleared therapy that allows pediatric patients to watch TV within a VR headset for one hour a day, six days a week as treatment.  

This is a completely reimagined approach to lazy eye therapy. For decades, patients have been required to undergo eye-patching, which forces them to cover their “good eye” and go through their lives with poor vision, making everyday tasks and activities difficult. Luminopia works differently from eye-patching and doesn’t require patients to cover up their good eye; instead, it encourages the brain to use both eyes together. 

This collaboration with Crunchyroll, a subsidiary of Sony Pictures Entertainment, is a natural extension of Sony Innovation Fund’s investment in Luminopia. Crunchyroll  joins Luminopia’s growing roster of content partners, including Nickelodeon, PBS Kids and Sesame Workshop. Most recently, Luminopia partnered with Pokémon to bring hundreds of episodes of the original animated series to its platform.

Parents and guardians of children with amblyopia can inquire about Luminopia with their eye doctors today. It’s being prescribed in top eye institutes, children’s hospitals and private practices across the U.S.


Discover more from Graphic Policy

Subscribe to get the latest posts sent to your email.